The University of Southampton
University of Southampton Institutional Repository

Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation

Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation
Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation
Background: Age-related macular degeneration is the most common cause of sight impairment in the UK. In neovascular age-related macular degeneration (nAMD), vision worsens rapidly (over weeks) due to abnormal blood vessels developing that leak fluid and blood at the macula.

Objectives: To determine the optimal role of optical coherence tomography (OCT) in diagnosing people newly presenting with suspected nAMD and monitoring those previously diagnosed with the disease.

Data sources: Databases searched: MEDLINE (1946 to March 2013), MEDLINE In-Process & Other Non-Indexed Citations (March 2013), EMBASE (1988 to March 2013), Biosciences Information Service (1995 to March 2013), Science Citation Index (1995 to March 2013), The Cochrane Library (Issue 2 2013), Database of Abstracts of Reviews of Effects (inception to March 2013), Medion (inception to March 2013), Health Technology Assessment database (inception to March 2013).

Review methods: Types of studies: direct/indirect studies reporting diagnostic outcomes. Index test: time domain optical coherence tomography (TD-OCT) or spectral domain optical coherence tomography (SD-OCT). Comparators: clinical evaluation, visual acuity, Amsler grid, colour fundus photographs, infrared reflectance, red-free images/blue reflectance, fundus autofluorescence imaging, indocyanine green angiography, preferential hyperacuity perimetry, microperimetry. Reference standard: fundus fluorescein angiography (FFA). Risk of bias was assessed using quality assessment of diagnostic accuracy studies, version 2. Meta-analysis models were fitted using hierarchical summary receiver operating characteristic curves. A Markov model was developed (65-year-old cohort, nAMD prevalence 70%), with nine strategies for diagnosis and/or monitoring, and cost–utility analysis conducted. NHS and Personal Social Services perspective was adopted. Costs (2011/12 prices) and quality-adjusted life-years (QALYs) were discounted (3.5%). Deterministic and probabilistic sensitivity analyses were performed.

Results: In pooled estimates of diagnostic studies (all TD-OCT), sensitivity and specificity [95% confidence interval (CI)] was 88% (46% to 98%) and 78% (64% to 88%) respectively. For monitoring, the pooled sensitivity and specificity (95% CI) was 85% (72% to 93%) and 48% (30% to 67%) respectively. The FFA for diagnosis and nurse-technician-led monitoring strategy had the lowest cost (£39,769; QALYs 10.473) and dominated all others except FFA for diagnosis and ophthalmologist-led monitoring (£44,649; QALYs 10.575; incremental cost-effectiveness ratio £47,768). The least costly strategy had a 46.4% probability of being cost-effective at £30,000 willingness-to-pay threshold.

Limitations: Very few studies provided sufficient information for inclusion in meta-analyses. Only a few studies reported other tests; for some tests no studies were identified. The modelling was hampered by a lack of data on the diagnostic accuracy of strategies involving several tests.

Conclusions: Based on a small body of evidence of variable quality, OCT had high sensitivity and moderate specificity for diagnosis, and relatively high sensitivity but low specificity for monitoring. Strategies involving OCT alone for diagnosis and/or monitoring were unlikely to be cost-effective. Further research is required on (i) the performance of SD-OCT compared with FFA, especially for monitoring but also for diagnosis; (ii) the performance of strategies involving combinations/sequences of tests, for diagnosis and monitoring; (iii) the likelihood of active and inactive nAMD becoming inactive or active respectively; and (iv) assessment of treatment-associated utility weights (e.g. decrements), through a preference-based study.

Study registration: This study is registered as PROSPERO CRD42012001930.

Funding: The National Institute for Health Research Health Technology Assessment programme.
1366-5278
1-254
Mowatt, Graham
49d22771-a3ea-4ee1-8b6a-0577e494fb91
Hernandez, Rodolfo
adb86a7d-9359-4998-9d4e-a3e9091c4fab
Castillo, Mayret
1aef51af-fc96-4808-b1e5-443c9f64fcda
Lois, Noemi
bbac68dd-a228-47f1-91b8-b4b0340a2e7b
Elders, Andrew
f82e20bf-ea3b-4aff-aeb4-c149e11def60
Fraser, Cynthia
66578e93-8ce5-4c61-89c7-e11315152d5d
Aremu, Olatunde
5049b52a-2ef1-4e86-b108-71b07946221a
Amoaku, Winfried
c438c8d7-a9f4-4c49-b568-d35138deb061
Burr, Jennifer
839aa0b6-6263-4a6b-8fb6-669838ebdd6d
Lotery, Andrew J.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Ramsay, Craig
2f8071ed-9d54-4d8a-9473-d8fa15d5e6d5
Azuara-Blanco, Augusto
b67a8c87-d4bf-451a-b199-9356ef3b3534
Mowatt, Graham
49d22771-a3ea-4ee1-8b6a-0577e494fb91
Hernandez, Rodolfo
adb86a7d-9359-4998-9d4e-a3e9091c4fab
Castillo, Mayret
1aef51af-fc96-4808-b1e5-443c9f64fcda
Lois, Noemi
bbac68dd-a228-47f1-91b8-b4b0340a2e7b
Elders, Andrew
f82e20bf-ea3b-4aff-aeb4-c149e11def60
Fraser, Cynthia
66578e93-8ce5-4c61-89c7-e11315152d5d
Aremu, Olatunde
5049b52a-2ef1-4e86-b108-71b07946221a
Amoaku, Winfried
c438c8d7-a9f4-4c49-b568-d35138deb061
Burr, Jennifer
839aa0b6-6263-4a6b-8fb6-669838ebdd6d
Lotery, Andrew J.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Ramsay, Craig
2f8071ed-9d54-4d8a-9473-d8fa15d5e6d5
Azuara-Blanco, Augusto
b67a8c87-d4bf-451a-b199-9356ef3b3534

Mowatt, Graham, Hernandez, Rodolfo, Castillo, Mayret, Lois, Noemi, Elders, Andrew, Fraser, Cynthia, Aremu, Olatunde, Amoaku, Winfried, Burr, Jennifer, Lotery, Andrew J., Ramsay, Craig and Azuara-Blanco, Augusto (2014) Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation. Health Technology Assessment, 18 (69), 1-254. (doi:10.3310/hta18690). (PMID:25436855)

Record type: Article

Abstract

Background: Age-related macular degeneration is the most common cause of sight impairment in the UK. In neovascular age-related macular degeneration (nAMD), vision worsens rapidly (over weeks) due to abnormal blood vessels developing that leak fluid and blood at the macula.

Objectives: To determine the optimal role of optical coherence tomography (OCT) in diagnosing people newly presenting with suspected nAMD and monitoring those previously diagnosed with the disease.

Data sources: Databases searched: MEDLINE (1946 to March 2013), MEDLINE In-Process & Other Non-Indexed Citations (March 2013), EMBASE (1988 to March 2013), Biosciences Information Service (1995 to March 2013), Science Citation Index (1995 to March 2013), The Cochrane Library (Issue 2 2013), Database of Abstracts of Reviews of Effects (inception to March 2013), Medion (inception to March 2013), Health Technology Assessment database (inception to March 2013).

Review methods: Types of studies: direct/indirect studies reporting diagnostic outcomes. Index test: time domain optical coherence tomography (TD-OCT) or spectral domain optical coherence tomography (SD-OCT). Comparators: clinical evaluation, visual acuity, Amsler grid, colour fundus photographs, infrared reflectance, red-free images/blue reflectance, fundus autofluorescence imaging, indocyanine green angiography, preferential hyperacuity perimetry, microperimetry. Reference standard: fundus fluorescein angiography (FFA). Risk of bias was assessed using quality assessment of diagnostic accuracy studies, version 2. Meta-analysis models were fitted using hierarchical summary receiver operating characteristic curves. A Markov model was developed (65-year-old cohort, nAMD prevalence 70%), with nine strategies for diagnosis and/or monitoring, and cost–utility analysis conducted. NHS and Personal Social Services perspective was adopted. Costs (2011/12 prices) and quality-adjusted life-years (QALYs) were discounted (3.5%). Deterministic and probabilistic sensitivity analyses were performed.

Results: In pooled estimates of diagnostic studies (all TD-OCT), sensitivity and specificity [95% confidence interval (CI)] was 88% (46% to 98%) and 78% (64% to 88%) respectively. For monitoring, the pooled sensitivity and specificity (95% CI) was 85% (72% to 93%) and 48% (30% to 67%) respectively. The FFA for diagnosis and nurse-technician-led monitoring strategy had the lowest cost (£39,769; QALYs 10.473) and dominated all others except FFA for diagnosis and ophthalmologist-led monitoring (£44,649; QALYs 10.575; incremental cost-effectiveness ratio £47,768). The least costly strategy had a 46.4% probability of being cost-effective at £30,000 willingness-to-pay threshold.

Limitations: Very few studies provided sufficient information for inclusion in meta-analyses. Only a few studies reported other tests; for some tests no studies were identified. The modelling was hampered by a lack of data on the diagnostic accuracy of strategies involving several tests.

Conclusions: Based on a small body of evidence of variable quality, OCT had high sensitivity and moderate specificity for diagnosis, and relatively high sensitivity but low specificity for monitoring. Strategies involving OCT alone for diagnosis and/or monitoring were unlikely to be cost-effective. Further research is required on (i) the performance of SD-OCT compared with FFA, especially for monitoring but also for diagnosis; (ii) the performance of strategies involving combinations/sequences of tests, for diagnosis and monitoring; (iii) the likelihood of active and inactive nAMD becoming inactive or active respectively; and (iv) assessment of treatment-associated utility weights (e.g. decrements), through a preference-based study.

Study registration: This study is registered as PROSPERO CRD42012001930.

Funding: The National Institute for Health Research Health Technology Assessment programme.

Text
FullReport-hta18690.pdf - Version of Record
Download (2MB)

More information

Published date: 18 December 2014
Organisations: Faculty of Medicine

Identifiers

Local EPrints ID: 372396
URI: http://eprints.soton.ac.uk/id/eprint/372396
ISSN: 1366-5278
PURE UUID: fc0ccf68-0308-4619-b9f8-ff870d24ce83
ORCID for Andrew J. Lotery: ORCID iD orcid.org/0000-0001-5541-4305

Catalogue record

Date deposited: 03 Dec 2014 12:08
Last modified: 26 Nov 2019 01:48

Export record

Altmetrics

Contributors

Author: Graham Mowatt
Author: Rodolfo Hernandez
Author: Mayret Castillo
Author: Noemi Lois
Author: Andrew Elders
Author: Cynthia Fraser
Author: Olatunde Aremu
Author: Winfried Amoaku
Author: Jennifer Burr
Author: Craig Ramsay
Author: Augusto Azuara-Blanco

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×